Jan 17, 2013

Farmak JSC has improved the formula of Injesta ampoule progesterone

Farmak’s specialists have improved the formula of Injesta ampoule progesterone. The improved preparation is produced under “Injesta” name. The medicine has wide indications range in obstetrics and gynaecology.

Injesta is produced in form of 1% or 2,5% solution for injections. The medicine contains a new form of ethyl oleate with viscosity 13 times less than oil solution that allows quicker medicine absorption and its quicker and entire dissolution in tissues. It also ensures accurate and constant progesterone concentration in blood, and it is well-resolved (this prevents graomas and abscesses in place of injection), and ensures painless injections.

Natalia Levchenko, Farmak’s Specialist of Ophthalmologic and Dermatological Drugs Department: “Injesta has wide indications range in obstetrics and gynaecology”. In particular, in case of non-carrying of pregnancy, threat of miscarriage, amenorrhea, dysfunctional metrorrhagia, sterility.

 

 

Back to the News

More news